Dr. Wiland, et al, reply

J Rheumatol. 2017 Feb;44(2):259. doi: 10.3899/jrheum.161405.

Authors

Piotr Wiland¹, Jean Dudler², Douglas Veale³, Hasan Tahir⁴, Ron Pedersen⁵, Jack Bukowski⁵, Bonnie Vlahos⁵, Theresa Williams⁵, Stefanie Gaylord⁵, Sameer Kotak⁶

Affiliations

¹ Head of Department, Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland; [email protected].
² Clinic of Rheumatology, HFR Fribourg, Hôpital Cantonal, Fribourg, Switzerland.
³ Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland.
⁴ Barts Health National Health Service Trust, London, UK.
⁵ Pfizer Inc.
⁶ Pfizer Inc., Collegeville, Pennsylvania, USA.

PMID: 28148758
DOI: 10.3899/jrheum.161405

No abstract available

Publication types

Letter
Comment